Aug 27, 2024
Industry and Company News
Announcements in the third quarter 2024 include recognition for our Claims team, a new article by Bob White featured in Fortune, and affirmation of our commitment to health workforce well-being.
From
The Doctor’s Advocate
Search
September 01, 2023, Part B News
Head Off Problem Patients With Signed Agreements, Legal Review: Expert
Richard F. Cahill, Esq., Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, discusses the rights and responsibilities of practice managers who wish to remove or stop admitting troublesome patients.
January 31, 2022, Medscape
Medscape Ob/Gyn Malpractice Report 2021
Peter Kolbert, JD, Senior Vice President of Claim and Litigation Services for Healthcare Risk Advisors, part of TDC Group, notes why ob/gyn carries significant financial exposure with lawsuits.
Professional Education
Module 3: Safe Prescribing of Opioids and CNS Depressants (Innovations and Smart Approaches in Safe Prescribing)
Learn several new concepts and innovation tips. Learn about the new CDC Guidelines about pain. This program will show how to treat pain, opioid withdrawal, and/or opioid addiction. It will show how to taper opioids and you will learn how to conduct “motivational interviewing.” You will examine multimodal approaches for chronic pain, including physical, psych-behavioral, procedural, and pharmacological modalities. You will be encouraged to use tools for prescribing and tapering opioids and benzodiazepines. You will be provided with an overview of the use of CURES 2.0. Lastly, the program will examine how to best screen patients for use of CNS depressants and marijuana to mitigate the potential for contraindications with opioids. This module consists of seven audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Jan 23, 2023
Medical Malpractice Claims-Made Social Inflation and Loss Development Report
Using insurance company annual statement data, the “Medical Malpractice Claims-Made Social Inflation and Loss Development Report” estimates that in the decade ending in 2021, between $2.4 and $3.5 billion, or 8 to 11 percent, of all medical malpractice losses incurred by physician-focused insurers stemmed from social inflation.
June 10, 2024, The Podcast by KevinMD
AI, the Physician Shortage, and Other Healthcare Trends
Richard E. Anderson, MD, FACP, Chairman and Chief Executive Officer of The Doctors Company and TDC Group, discusses issues shaping the future of U.S. healthcare, from the impact of AI-powered clinical decision support tools to strategies for addressing physician shortages and managing healthcare costs amid consolidation.
February 06, 2024
TDC Group Appoints Daniel Kent Cassavar, MD, MBA, as Medical Director
TDC Group announced today the appointment of Daniel Kent Cassavar, MD, MBA, as Medical Director. Dr. Cassavar is a member of The Doctors Company’s Board of Governors, is a practicing cardiologist, and has held significant leadership roles in healthcare.
Video Jul 29, 2024
Why Do Large Verdicts Influence the 1% of Cases We Lose and How Does This Effect MPL Rates?
In 2010, there were 18 nuclear verdicts totaling $10 million or more in the United States. By the end of 2023, there were 58 of these large verdicts, meaning there was at least one nuclear verdict occurring every week across the U.S. The bad news? 2024 is on pace to equal or surpass what transpired in 2023. Robert White, President of The Doctors Company and TDC Group, discusses how large verdicts are creating a domino effect on medical professional liability rates.
March 14, 2022, KevinMD
Tackling Trial Delays, Social Inflation, and Skeptical Jurors in a Pandemic World
Marco Spadacenta, Senior Vice President of Claims for The Doctors Company, discusses the changing face of trials and jurors and suggests what can be done in light of these changes to successfully defend physicians in medical malpractice cases.